TAHO Pharma (6467) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 泰合

TAHO Pharma (6467) reported revenue of NT$10,000 for Oct 2026, -99.2% from the previous month. Revenue for Jan–Oct 2026 was NT$5.9 million (-24.2% year on year).

In Oct 2026, it ranked No. 154 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Jan 2025 NT$244,00025/01Feb 2025 NT$1.5 millionMar 2025 NT$1.2 million25/03Apr 2025 NT$3.1 millionMay 2025 NT$1.7 million25/05Aug 2025 NT$58,000Nov 2025 NT$418,00025/11Dec 2025 NT$131,000Jan 2026 NT$23,00026/01Mar 2026 NT$10,000Jun 2026 NT$1.3 million26/06Jul 2026 NT$1.7 millionAug 2026 NT$1.7 million26/08Sep 2026 NT$1.2 millionOct 2026 NT$10,00026/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$10,000—-99.2%
Sep 2026NT$1.2 million—-31.3%
Aug 2026NT$1.7 million+2,874.1%+3.2%
Jul 2026NT$1.7 million—+26.8%
Jun 2026NT$1.3 million——
May 2026NT$0-100.0%—
Apr 2026NT$0-100.0%-100.0%
Mar 2026NT$10,000-99.2%—
Feb 2026NT$0-100.0%-100.0%
Jan 2026NT$23,000-90.6%-82.4%
Dec 2025NT$131,000—-68.7%
Nov 2025NT$418,000——
Oct 2025NT$0——
Sep 2025NT$0—-100.0%
Aug 2025NT$58,000——
Jul 2025NT$0——
Jun 2025NT$0—-100.0%
May 2025NT$1.7 million—-44.2%
Apr 2025NT$3.1 million—+151.1%
Mar 2025NT$1.2 million—-20.2%
Feb 2025NT$1.5 million—+527.9%
Jan 2025NT$244,000——
Dec 2024NT$0——
Nov 2024NT$0——
Oct 2024NT$0——

Jan–Oct 2026 cumulative: NT$5.9 million (-24.2% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: TAHO Pharma vs PEC / TAHO Pharma vs Lotus Pharm / TAHO Pharma vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

主要品項仍在研發階段

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16